Total Payments
$79,606
2024 Payments
$13,665
Companies
25
Transactions
141
Medicare Patients
5,000
Medicare Billing
$1.0M
Payment Breakdown by Category
Other$63,681 (80.0%)
Travel$6,195 (7.8%)
Consulting$5,688 (7.1%)
Food & Beverage$3,978 (5.0%)
Education$64.37 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $63,660 | 31 | 80.0% |
| Travel and Lodging | $6,195 | 22 | 7.8% |
| Consulting Fee | $5,688 | 2 | 7.1% |
| Food and Beverage | $3,978 | 81 | 5.0% |
| Education | $64.37 | 4 | 0.1% |
| Debt forgiveness | $20.50 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Relypsa, Inc. | $42,496 | 61 | $0 (2020) |
| Vifor Pharma, Inc. | $35,672 | 41 | $0 (2024) |
| Amgen Inc. | $154.17 | 3 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $148.82 | 4 | $0 (2024) |
| Medtronic, Inc. | $139.88 | 2 | $0 (2024) |
| Horizon Pharma plc | $125.00 | 1 | $0 (2018) |
| GlaxoSmithKline, LLC. | $113.69 | 2 | $0 (2021) |
| Mallinckrodt Hospital Products Inc. | $109.37 | 1 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $99.97 | 1 | $0 (2017) |
| Otsuka America Pharmaceutical, Inc. | $86.12 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13,665 | 25 | Vifor Pharma, Inc. ($13,366) |
| 2023 | $5,705 | 10 | Vifor Pharma, Inc. ($5,467) |
| 2022 | $13,246 | 17 | Vifor Pharma, Inc. ($13,246) |
| 2021 | $3,724 | 10 | Vifor Pharma, Inc. ($3,592) |
| 2020 | $2,133 | 4 | Relypsa, Inc. ($2,114) |
| 2019 | $16,451 | 29 | Relypsa, Inc. ($16,289) |
| 2018 | $24,358 | 37 | Relypsa, Inc. ($24,066) |
| 2017 | $323.43 | 9 | Amgen Inc. ($106.75) |
All Payment Transactions
141 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,420.00 | General |
| Category: Hyperkalemia | ||||||
| 11/13/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $120.80 | General |
| Category: Hyperkalemia | ||||||
| 11/13/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Travel and Lodging | In-kind items and services | $82.68 | General |
| Category: Hyperkalemia | ||||||
| 11/08/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,210.00 | General |
| Category: Hyperkalemia | ||||||
| 11/07/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,630.00 | General |
| Category: Hyperkalemia | ||||||
| 11/07/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Travel and Lodging | In-kind items and services | $246.56 | General |
| Category: Hyperkalemia | ||||||
| 11/07/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $120.18 | General |
| Category: Hyperkalemia | ||||||
| 09/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Cardio-renal | ||||||
| 09/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: Immunology | ||||||
| 06/25/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,117.50 | General |
| Category: Hyperkalemia | ||||||
| 06/25/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $121.12 | General |
| Category: Hyperkalemia | ||||||
| 06/14/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 06/14/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.38 | General |
| 05/13/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Phosphate binder for ESRD | ||||||
| 05/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/22/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: NEPHROLOGY | ||||||
| 04/19/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,025.00 | General |
| Category: Hyperkalemia | ||||||
| 04/19/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Travel and Lodging | In-kind items and services | $147.40 | General |
| Category: Hyperkalemia | ||||||
| 04/19/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Hyperkalemia | ||||||
| 02/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Cardio-renal | ||||||
| 01/31/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: NEPHROLOGY | ||||||
| 01/26/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $65.75 | General |
| Category: EndoVenous Therapies | ||||||
| 01/16/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: NEPHROLOGY | ||||||
| 01/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Cardio-renal | ||||||
| 01/08/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $25.51 | General |
| Category: NEPHROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,595 | 3,931 | $1.2M | $279,979 |
| 2022 | 13 | 963 | 1,979 | $823,297 | $212,166 |
| 2021 | 15 | 1,152 | 2,664 | $1.0M | $290,239 |
| 2020 | 20 | 1,290 | 3,859 | $641,396 | $261,376 |
Total Patients
5,000
Total Services
12,433
Medicare Billing
$1.0M
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 41 | 243 | $256,557 | $65,895 | 25.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 311 | 705 | $269,658 | $50,049 | 18.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 227 | 577 | $131,677 | $35,952 | 27.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 90 | 558 | $103,819 | $27,268 | 26.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 139 | 622 | $92,554 | $24,652 | 26.6% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 119 | 372 | $53,892 | $14,411 | 26.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 93 | 99 | $53,074 | $13,282 | 25.0% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 29 | 56 | $49,075 | $12,274 | 25.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 62 | 65 | $25,385 | $6,626 | 26.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 77 | 90 | $24,329 | $5,502 | 22.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 35 | 49 | $16,945 | $4,635 | 27.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 40 | 40 | $19,949 | $4,534 | 22.7% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 46 | 71 | $15,150 | $3,866 | 25.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 33 | $17,655 | $3,284 | 18.6% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 40 | 80 | $11,275 | $2,948 | 26.1% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 147 | 168 | $9,581 | $2,544 | 26.6% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 34 | 64 | $7,534 | $2,015 | 26.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 11 | 12 | $836.52 | $148.56 | 17.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 27 | 27 | $281.88 | $92.07 | 32.7% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 40 | 239 | $244,373 | $67,081 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 275 | 587 | $222,663 | $53,433 | 24.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 253 | 680 | $145,509 | $38,071 | 26.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 116 | 116 | $69,336 | $17,954 | 25.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 20 | 40 | $34,604 | $9,187 | 26.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 62 | 62 | $31,234 | $6,961 | 22.3% |
About Dr. Deep Patel, MD
Dr. Deep Patel, MD is a Nephrology healthcare provider based in Mechanicsville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2008. The National Provider Identifier (NPI) number assigned to this provider is 1154593168.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deep Patel, MD has received a total of $79,606 in payments from pharmaceutical and medical device companies, with $13,665 received in 2024. These payments were reported across 141 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($63,660).
As a Medicare-enrolled provider, Patel has provided services to 5,000 Medicare beneficiaries, totaling 12,433 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Mechanicsville, VA
- Active Since 03/31/2008
- Last Updated 02/04/2026
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1154593168
Products in Payments
- Veltassa (Drug) $71,350
- LOKELMA (Drug) $132.15
- KRYSTEXXA (Drug) $125.00
- BENLYSTA (Biological) $113.69
- TERLIVAZ (Drug) $109.37
- Parsabiv (Biological) $106.75
- XARELTO (Drug) $99.97
- JYNARQUE (Drug) $86.12
- Kerendia (Drug) $80.35
- ELLIPSYS VASCULAR ACCESS SYSTEM (Device) $74.13
- THYMOGLOBULIN (Drug) $69.23
- VENASEAL (Device) $65.75
- Aranesp (Biological) $47.42
- Auryxia (Drug) $47.16
- KRYSTEXXA (Biological) $26.73
- TREMFYA (Drug) $26.09
- AURYXIA (Drug) $21.43
- ENTRESTO (Drug) $20.95
- None (Device) $20.50
- Velphoro (Drug) $18.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Mechanicsville
Mary Mcneer, Md, MD
Nephrology — Payments: $2,453
Nephrology $2,453
Dr. Amar Damodar, M.d, M.D
Nephrology — Payments: $2,165
Nephrology $2,165
Muhammad Yaseen, Md, MD
Nephrology — Payments: $1,925
Nephrology $1,925
Satish Patel, M.d, M.D
Nephrology — Payments: $1,460
Nephrology $1,460
Swapna Kallu, Md, MD
Nephrology — Payments: $1,229
Nephrology $1,229
Bhavesh Patel, Md, MD
Nephrology — Payments: $959.64
Nephrology $959.64